Tolerability of Enecadin (INN) in Acute Ischemic Stroke Trial - TEST

NCT00331721 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped Scientific data called into question the viability of the substance class

Conditions

Interventions

Sponsor

PAION Deutschland GmbH